ResDAC is currently experiencing a high volume of requests, which may delay response and processing times. We are working to address the backlog as quickly as possible and appreciate your patience.
ResDAC is currently experiencing a high volume of requests, which may delay response and processing times. We are working to address the backlog as quickly as possible and appreciate your patience.
Formatted as MMDDYY10 in SAS
In OCM, episodes were initiated on the date of service for an initial Part B chemotherapy drug claim with a corresponding cancer diagnosis on the claim, or on the fill date for an initial Part D chemotherapy drug claim with a corresponding Part B claim for cancer on the date of, or in the 59 days preceding, the drug claim (variable called EPSD_BGN_DT). Episodes continued for six months after the triggering chemotherapy event, as long as the beneficiary met eligibility requirements for all six months; the ending date of the episode is this variable (EPSD_END_DT). Beneficiaries who continued to receive chemotherapy after completing the six-month episode initiated a new episode.